Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
306.50    -4.00 (-1.29%)
Bid:
306.00
Ask:
307.50
Spread: 1.50 (0.49%)
Market Cap: £183.25m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Transaction in Own Shares

12 Feb 2025 07:00

RNS Number : 7571W
Liontrust Asset Management PLC
12 February 2025
 

LEI: 549300XVXU6S7PLCL855

 

12 February 2025

 

Liontrust Asset Management Plc

 

("Liontrust" or the "Company")

 

Purchase of Own Shares

 

In accordance with the Company's Share Buyback programme, as outlined in its announcement on 28 November 2024, Liontrust announces that it has purchased 25,000 of its ordinary shares ("Shares") at a price of 453.8 pence per Share. The purchased Shares will be cancelled.

 

Aggregated information

 

Date of purchase

11 February 2025

Number of Shares purchased

25,000

Highest price paid per Share

455.00

Lowest price paid per Share

452.00

Volume weighted average price paid

453.80

 

 

Transaction details

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:

 

Number of Shares purchased

Transaction price (GBp)

Time of transaction

Trading venue

15,000

 455.00

11:17:05

XLON

10,000

 452.00

11:41:55

XLON

 

Total voting rights  

Following the purchase, the Company's total issued share capital consists of 64,210,000 Shares. The Company does not hold any Shares in treasury therefore, the total number of Shares carrying voting rights in the Company is 64,210,000.

The above figure of 64,210,000 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:

Teneo (Tel: 020 7353 4200, Email: liontrust@teneo.com)

Tom Murray, Colette Cahill, Jessica Pine

 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.co.uk)

Stephen Corbett: Head of Investor Relations

Simon Hildrey: Chief Marketing Officer

 

Singer Capital Markets (Tel: 020 7496 3000)

Corporate Broking: Charles Leigh-Pemberton

Corporate Advisory: James Moat

 

Panmure Liberum (Tel: 020 7886 2500)

Corporate Broking: David Watkins

Corporate Advisory: Atholl Tweedie

 

HSBC Bank plc (Tel: 020 7991 8888)

Corporate Broking: Simon Alexander, James Hopton

Corporate Advisory: Alexander Paul

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKFLFFELLFBBF
Date   Source Headline
2nd Feb 20267:05 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20263:22 pmRNSForm 8.3 -KITWAVE GROUP PLC
29th Jan 20263:19 pmRNSForm 8.3 - Auction Technology Group
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20262:45 pmRNSForm 8.3 - Oxford Biomedica Plc
28th Jan 20262:40 pmRNSForm 8.3 - Kitwave Group Plc
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20263:25 pmRNSForm 8.3 - Auction Technology Group Plc
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20262:08 pmRNSForm 8.3 - Oxford Biomedica Plc
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:40 pmRNSForm 8.3 - Auction Technology Group PLC
14th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTrading Statement
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20263:17 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20263:29 pmRNSHolding(s) in Company
2nd Jan 202611:08 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20254:00 pmRNSDirector/PDMR Shareholding
19th Dec 20254:00 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20255:44 pmRNSForm 8.3 - INSPECS GROUP PLC
12th Dec 20255:27 pmRNSForm 8.3 - INSPECS GROUP PLC
11th Dec 20251:42 pmRNSForm 8.3 - INSPECS GROUP PLC
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20253:03 pmRNSForm 8.3 - INSPECS GROUP PLC
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20253:36 pmRNSForm 8.3 - INSPECS GROUP PLC
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20254:02 pmRNSForm 8.3 - ESSENSYS PLC
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20252:23 pmRNSForm 8.3 - INSPECS GROUP PLC
2nd Dec 20251:19 pmRNSForm 8.3 - INSPECS GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.